The epidemiology of Stenotrophomonas maltophilia and Achromobacter xylosoxidans infections

Shani Zilberman-Itskovich*, Edward Cohen, Leonid Arie Ploshansky, Alexander Yusupov, Ruth Bouganim, Katie H. Jaffe, Dror Marchaim

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Stenotrophomonas maltophilia and Achromobacter xylosoxidans are emerging nosocomial, non-glucose fermenting, Gram-negative pathogens. In this nested case-control trial, independent predictors for S. maltophilia infections were hemodialysis and recent antibiotic usage (overall), while recent usage of fluoroquinolones, was independently associated with A. xylosoxidans infections. Infections were independently associated with multiple worse outcomes.

Original languageEnglish
Article numbere18
JournalAntimicrobial Stewardship and Healthcare Epidemiology
Volume4
Issue number1
DOIs
StatePublished - 2 Feb 2024

Fingerprint

Dive into the research topics of 'The epidemiology of Stenotrophomonas maltophilia and Achromobacter xylosoxidans infections'. Together they form a unique fingerprint.

Cite this